Vectibix

Vectibix Indications/Uses

panitumumab

Manufacturer:

Amgen

Distributor:

Zuellig Pharma
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
VECTIBIX in combination with oxaliplatin-based chemotherapy is indicated for the treatment of patients with wild-type RAS metastatic colorectal cancer (mCRC).
VECTIBIX is indicated for the treatment of patients with wild-type RAS metastatic colorectal cancer (mCRC) in combination with irinotecan-based chemotherapy.
VECTIBIX monotherapy is indicated for the treatment of patients with wild-type RAS mCRC after failure of standard chemotherapy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in